Loading clinical trials...

The Effects of Omega-3 Fatty Acids on Metabolic Syndrome | Clinical Trials | Clareo Health

UNKNOWNEARLY Phase 1NCT00350194

The Effects of Omega-3 Fatty Acids on Metabolic Syndrome

The purpose of this study is to determine the effects of omega-3 fatty acids in the form of fish oil supplementation (approximately 2 grams per day) on the carotid intima-media (CIMT)progression (prim...

Lead sponsor: University of Washington•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGNA

Study for the Identification of a Score to Assess Intrapancreatic Fat Through Eco-Elastography and Its Correlation With Metabolic Syndrome and Insulin-Secreting Cells.

NCT06801769 · Pancreatic Steatosis, Metabolic Syndrome X, and more

RECRUITINGNA

Identification of a Score for the Assessment of Intrapancreatic Fat

NCT07155473 · Pancreatic Steatosis, Metabolic Syndrome X, and more

RECRUITINGNA

Evaluation of a New Ultrasound System for the Non-invasive Assessment of Liver Steatosis in MASLD/MASH Patients

NCT06661655 · Metabolic Syndrome X, Fatty Liver, and more

RECRUITINGNA

Nursing Intervention in Weight and Metabolic Syndrome Management in First-episode Psychosis (MetaKOP)

NCT06650943 · First Episode Psychosis (FEP), Metabolic Syndrome X

RECRUITING

The Early Warning System for the Diabetic Encephalopathy

NCT02420470 · Diabetes Mellitus Type 2, Mild Cognitive Impairment, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 2, 2012Terms

Trial snapshot

StatusUNKNOWN

PhaseEARLY_PHASE1

Enrollment100

Start dateOct 2006

Last updatedMar 2, 2012

Condition

Metabolic Syndrome X

Locations shown

Northwest Lipid Research Clinic (University of Washington Affiliated)

Seattle, Washington

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 2, 2012Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

The Effects of Omega-3 Fatty Acids on Metabolic Syndrome

What this study is about

Save this trial guide to your notes

Sponsors

Related studies

Study for the Identification of a Score to Assess Intrapancreatic Fat Through Eco-Elastography and Its Correlation With Metabolic Syndrome and Insulin-Secreting Cells.

Identification of a Score for the Assessment of Intrapancreatic Fat

Evaluation of a New Ultrasound System for the Non-invasive Assessment of Liver Steatosis in MASLD/MASH Patients

Nursing Intervention in Weight and Metabolic Syndrome Management in First-episode Psychosis (MetaKOP)

The Early Warning System for the Diabetic Encephalopathy

Trial snapshot

Condition

Locations shown

For caregivers